Applied DNA, Alphazyme Agreement for Scale-Up Linea™ RNAP
March 18th, 2024
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
APDN to Showcase Linea™ DNA, Linea™ IVT Platforms at World Vaccine Congress
March 14th, 2024
APDN Announces Fourth Quarter Fiscal Year 2023 Financial Results
February 8th, 2024
APDN to Report FQ1’2024 Financial Results on Thursday, February 8, 2024
February 5th, 2024
APDN Announces $3.44M Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 31st, 2024
APDN Announces JDA to Integrate Linea™ IVT Platform into Kudo Biotechnology’s mRNA Manufacturing Workflow
December 14th, 2023
APDN Announces Fourth Quarter Fiscal Year 2023 Financial Results
December 7th, 2023
APDN to Report FQ4’23 and Year End Financial Results 12/7/23
December 5th, 2023
APDN Announces Linea™ DNA Follow-On Order for Cancer Diagnostic Application
November 28th, 2023